Daroszewska Anna, Hocking Lynne J, McGuigan Fiona E A, Langdahl Bente, Stone Michael D, Cundy Tim, Nicholson Geoff C, Fraser William D, Ralston Stuart H
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen AB25 2ZD, UK.
J Bone Miner Res. 2004 Sep;19(9):1506-11. doi: 10.1359/JBMR.040602. Epub 2004 Jun 14.
To clarify the role of the TNFRSF11B gene encoding osteoprotegerin (OPG), in Paget's disease of bone (PDB) we studied TNFRSF11B polymorphisms in an association study of 690 UK subjects and in a worldwide familial study of 66 kindreds. We found that the G1181 allele of TNFRSF11B, encoding lysine at codon 3 of the OPG protein, predisposes to both sporadic and familial PDB.
Paget's disease of bone (PDB) is a common disorder characterized by focal abnormalities of bone turnover. Genetic factors are important in the pathogenesis of PDB, and studies have shown that inactivating mutations of the TNFRSF11B gene, encoding osteoprotegerin (OPG), cause the rare syndrome of juvenile Paget's disease. In this study, we sought to determine whether polymorphisms of the TNFRSF11B gene contribute to the pathogenesis of classical PDB.
We screened for polymorphisms of the TNFRSF11B gene by DNA sequencing of the proximal promoter, coding exons, and intron-exon boundaries in 20 PDB patients and 10 controls. Informative single nucleotide polymorphisms (SNPs), including a G1181C SNP, which predicts a lysine-asparagine substitution at codon 3 of the OPG signal peptide and haplotypes, were related to the presence of PDB in 312 cases compared with 378 controls and to transmission of PDB in 140 affected offspring from 66 kindreds with familial PDB.
The G1181 allele was significantly over-represented in PDB patients (chi(2) = 5.7, df = 1, p = 0.017, adjusted alpha = 0.024), equivalent to an odds ratio for PDB of 1.55 (95% CI: 1.11-2.16). The distribution of TNFRSF11B haplotypes significantly differed in sporadic PDB cases and controls (chi(2) = 30.2, df = 9, p < 0.001) because of over-representation of haplotypes containing the G1181 allele in cases. The family study showed that the most common haplotype containing the G1181 allele was transmitted more frequently than expected to 140 individuals with familial PDB (chi(2) = 7.35, df = 1, p < 0.01), and the transmission disequilibrium was even more pronounced in a subgroup of 78 familial PDB patients who did not carry mutations of the SQSTM1 gene (chi(2) = 8.44, df = 1, p < 0.005). We conclude that the G1181 allele of TNFRSF11B, encoding lysine at codon 3 of the OPG protein, predisposes to the development of sporadic PDB and familial PDB that is not caused by SQSTM1 mutations.
为明确编码骨保护素(OPG)的TNFRSF11B基因在佩吉特骨病(PDB)中的作用,我们在一项针对690名英国受试者的关联研究以及一项针对66个家族的全球家族性研究中,对TNFRSF11B基因多态性进行了研究。我们发现,TNFRSF11B基因的G1181等位基因,其在OPG蛋白第3密码子处编码赖氨酸,易导致散发性和家族性PDB。
佩吉特骨病(PDB)是一种常见疾病,其特征为骨转换的局灶性异常。遗传因素在PDB的发病机制中起重要作用,研究表明,编码骨保护素(OPG)的TNFRSF11B基因的失活突变会导致罕见的青少年佩吉特病综合征。在本研究中,我们试图确定TNFRSF11B基因多态性是否有助于经典PDB的发病机制。
我们通过对20例PDB患者和10例对照的近端启动子、编码外显子以及内含子 - 外显子边界进行DNA测序,筛选TNFRSF11B基因的多态性。包括G1181C单核苷酸多态性(SNP)(其预测OPG信号肽第3密码子处赖氨酸 - 天冬酰胺替换)和单倍型在内的信息性单核苷酸多态性,与312例病例和378例对照中PDB的存在情况相关,并与66个患有家族性PDB的家族中140名受影响后代的PDB传递情况相关。
G1181等位基因在PDB患者中显著过度表达(χ² = 5.7,自由度 = 1,p = 0.017,校正α = 0.024),相当于PDB的优势比为1.55(95%置信区间:1.11 - 2.16)。由于病例中包含G1181等位基因的单倍型过度表达,TNFRSF11B单倍型在散发性PDB病例和对照中的分布存在显著差异(χ² = 30.2,自由度 = 9,p < 0.001)。家族性研究表明,包含G1181等位基因的最常见单倍型传递给140名家族性PDB个体的频率高于预期(χ² = 7.35,自由度 = 1,p < 0.01),并且在未携带SQSTM1基因突变的78名家族性PDB患者亚组中,传递不平衡更为明显(χ² = 8.44,自由度 = 1,p < 0.005)。我们得出结论,TNFRSF11B基因的G1181等位基因,其在OPG蛋白第3密码子处编码赖氨酸,易导致散发性PDB以及非由SQSTM1突变引起的家族性PDB的发生。